Clinical effectiveness of lividomycin on urinary tract infections: evaluation with double-blind method.
D000328:Adult; D000368:Aged; D001437:Bacteriuria / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003556:Cystitis / Q000188:drug therapy; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D007677:Kidney Function Tests; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008111:Liver Function Tests; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010303:Paromomycin / Q000494:pharmacology / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy; D011468:Prostatectomy; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011704:Pyelonephritis / Q000188:drug therapy; D013997:Time Factors; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D007612:Kanamycin; D010303:Paromomycin